Panel Discussion: Accelerating our Ability to Unearth the Mechanism of Action of Biomarkers

Time: 3:00 pm
day: Conference Day One - Track One - PM


  • What are some of the major challenges for identifying and understanding biomarker MOA?
  • How are researchers developing a better test earlier? 
  • How are we overcoming the upfront investment?
  • What are the key challenges for validating different sets of biomarkers?
  • Why is sampling so important?
  • At what stage do we need to begin thinking about the CDx?
  • What platforms are being used and are they compliant?